Loading…

Relationship and significance between anti-β2-glycoprotein Ⅰ antibodies and platelet activation state in patients with ulcerative colitis

AIM: To study the relationship between anti-β2- glycoprotein Ⅰ (aβ2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance. METHODS: Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2008-02, Vol.14 (5), p.771-775
Main Author: Yan-Hang Gao Pu-Jun Gao Chun-Guang Wang Xiao-Cong Wang Yun-Feng Piao
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AIM: To study the relationship between anti-β2- glycoprotein Ⅰ (aβ2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance. METHODS: Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66 years), including 36 at active stage and 20 at remission stage, and 25 sex-and age-matched controls. The level of aβ2GP Ⅰ was measured by ELISA. The platelet activation markers, platelet activation complex- Ⅰ (PAC- Ⅰ ) and P-selectin (CD62P) were detected by flow cytometry. RESULTS: The A value for IgG aβ2GP Ⅰ in the active UC group was 0.61 ± 0.13, significantly higher than that in the remittent UC and control groups (0.50 ± 0.13 and 0.22 ± 0.14, P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). The A value for IgM aβ2GP Ⅰ in the active and remittent UC groups was 0.43 ± 0.13 and 0.38 ± 0.12, significantly higher than that in the control group (0.20 ± 0.12, P 〈 0.01). However, there was no significant difference between the two groups (P 〉 0.05). The PAC- Ⅰ positive rate for the active and remittent UC groups was 30.6% ± 7.6% and 19.6% ± 7.8% respectively, significantly higher than that for the control group (6.3% ± 1.7%,P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). The CD62P positive rate for the active and remittent UC groups was 45.0% ± 8.8% and 31.9% ± 7.8% respectively, significantly higher than that for the control group (9.2% ± 2.7%, P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). In the active UC group, the more severe the state of illness was, the higher the A value for IgG aβ2GP Ⅰ was, and the positive rate for PAC-Ⅰ and CD62P was positively correlated with the state of illness (Faβ2GP Ⅰ = 3.679, P 〈 0.05; FPAC-Ⅰ (%) = 5.346, P 〈 0.01; and FCD62P (%) = 5. 418, P 〈 0.01). Meanwhile, in the same state of illness, the A value for IgG aβ2GP Ⅰ was positively correlated to the positive rates for PAC-Ⅰ and CD62P. CONCLUSION: aβ2GP Ⅰ level, platelet activation state and their relationship of them are closely correlated with the pathogenesis and development of UC.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.14.771